Synthesis of Gallic-Acid-1-Phenyl-1H-[1,2,3]Triazol-4-yl Methyl Esters as Effective Antioxidants

Abstract

Using a click chemistry approach, a series of gallic-acid-1-phenyl-1H-[1,2,3]triazol-4-ylmethyl esters was synthesized to develop more effective antioxidants. The results of DPPH screening indicate that few of the synthesized analogs display better antioxidant effect compared to the standards. Among all, compounds, 9 and 20 displayed highest DPPH radical scavenging effect with IC₅₀ values as low as 6.4±0.2 and 7.9±0.4 µM respectively, compared to the standard ascorbic acid (IC₅₀=12±0.8 µM) and gallic acid (IC₅₀=9.0±0.6 µM). Compound 10 also displayed a potent antioxidant effect with IC₅₀ of 10.80±0.4 µM. This study provides an important aspect with regard to the use of these gallic-acid based synthetic antioxidants in food industry as dietary supplements.

Key words

gallic acid - ascorbic acid - triazoles - antioxidants - food-industry

^* Both the authors contributed equally

• References

• 1 Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956; 11: 298-300
• 2 Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. Oxford: Oxford University Press; 1997
• 3 Sies H. Antioxidants in disease, mechanisms and therapy. New York: Academic Press; 1996
• 4 Sies H. Biochemistry of oxidative stress. Angew Chem Internat Ed Eng 1986; 1058-1071
• 5 Devasagayam TPA, Tilak JC, Boloor KK et al. Free radicals and antioxidants in human health: Current status and future prospscts. JAPI 2004; 52: 794
• 6 Singh J, Rai GK, Upadhyay AK et al. Indian Journal of agricultural Sciences 2004; 74: 3-5
• 7 Isuzugawa K, Inoue MY. Ogihara, Catalase contents in cells determine sensitivity to the apoptosis inducer gallic acid. Biological & Pharmaceutical Bulletin 2001; 24: 249-253
• 8 Constant J. Alcohol, ischemic heart disease, and the French paradox Coronary Artery Disease 1997; 8: 645-649
• 9 Jadon A, Bhadauria M, Shukla S. Journal of Ethnopharmacology 2007; 109: 214-218
• 10 Kim YJ. Antimelanogenic and antioxidant properties of gallic acid. Biological & Pharmaceutical Bulletin 2007; 30: 1052-1055
• 11 Zhao J, Khan IA, Fronczek FR. Gallic acid. Acta Crystallographica 2011; 67: 316-317
• 12 Shahrzad S, Aoyagi KA, Winter A et al. Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. The Journal of Nutrition 2001; 131: 1207-1210
• 13 Locatellia C, Filippin-Monteirob FB, Creczynski-Pasab TB. Synthesis, antimicrobial evaluation and QSAR studies of gallic acid derivatives. http://dx.doi.org/10.1016/j.arabjc.2013.11.014
• 14 Xun L, Yalin L, Wenfang Xu. Design synthesis and biological evaluation of novel galloyl pyrollidine derivatives as potential antitumor agents. Bioorganic & Medicinal Chemistry 2006; 14: 1287-1293
• 15 Wu J, Mi JL, Zhou CH. Chin Pharm J 2007; 42: 404-409
• 16 Meng JP, Lu YH, Halqam I et al. Ginseng compounds: an update on their molecular mechanisms and medical applications. chin. J Biochem Pharm 2008; 29: 422-425
• 17 Meng JP, Geng RX, Zhou CH et al. Advances in the research of benzimidazole drugs. Chin. J New Drugs 2009; 18: 1505-1514
• 18 Shi Y, Zhou CH. Synthesis and evaluation of a class of new coumarin triazole derivatives as potential antimicrobial agents. Bioorg Med Chem Lett 2011; 21: 956-960
• 19 Shi Y, Zhou CH, Zhou XD et al. Synthesis and antimicrobial evaluation of coumarin-based benzotriazoles and their synergistic effects with chloromycin and fluconazole. Acta Pharm. Sinica 2011; 46: 798-810
• 20 Wan K, Zhang YY, Zhou YY et al. J Antibiot 2012; 37: 8
• 21 Pasqualotto AC, Thiele KO, Goldani LZ. Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole. Curr Opin Invest Drugs 2010; 11: 165-174
• 22 Fera MT, Camera EL, Sarro AD. New triazoles and echinocandins: mode of action, invitro activity and mechanisms of resistance. Expert Rev Anti-Infect Ther 2009; 7: 981-998
• 23 Sobue S, Tan K, Haug-Pihale G. The effects of hepatic impairment on the pharmacokinetics of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole. Pharmocol 2005; 59: 160-166
• 24 Nam NH, Sardari S, Selecky M et al. Carboxylic acids and phosphate ester derivatives of fluconazole: synthesis and antifungal activities. Bioorg Med Chem 2004; 12: 6255-6269
• 25 Mora SJ, Cormick MP, Milanesio ME et al. The photodynamic activity of a novel porphyrin derivative bearing a fluconazole structure in different media and against Candida albicans. Dyes Pigments 2010; 87: 234-240
• 26 Zhou CH, Meng KG, Fang JPB et al. CN Patent 2009 CN 101397276 (A)
• 27 Francavilla C, Low E, Nair S et al. Quaternary ammonium N,N-dichloroamines as topical, antimicrobial agents. Bioorg. Med Chem Lett 2009; 19: 2731-2734
• 28 Lone SH, Bhat KA, Naseer S et al. Isolation, cytotoxicity evaluation and HPLC-quantification of the chemical constituents from Artemisia amygdalina. Decne. Chromatogr B 2013; 940: 135-141
• 29 Lone SH, Bhat KA Shakeel-u-Rehman et al. Synthesis and biological evaluation of amino analogs of Ludartin: potent and selective cytotoxic agents. Bioorg Med Chem Lett 2013; 23: 4931-4934
• 30 Lone SH, Bhat KA, Majeed R et al. Click chemistry inspired facile synthesis and bioevaluation of novel triazolyl analogs of Ludartin. A Bioorg Med Chem Lett 2014; 24: 1047-1051
• 31 Lu Z, Nie G, Belton PS et al. Structure-activity relationship analysis of antioxidant ability and neuroprotective effect of gallic acid derivatives. Neurochemistry International 2006; 48: 263-274
• 32 Bozin B, Mimica-Dukic M, Simin N et al. Characterization of the volatile composition of essential oils of some Lamiaceae spices and the antimicrobial and antioxidant activities of the entire oils. J Agric Food Chem 2006; 54: 1822-1828